IU chemist signs agreement with biotech company
The IU Research and Technology Corporation recently agreed to a licensing arrangement with a Carmel, Ind. biotechnology company to develop pharmaceuticals. Marcadia Biotech agreed to develop medical drugs created by the IU-Bloomington Chemistry Department Chair Richard DiMarchi. DiMarchi, a founding member of the biotechnology company, employs biochemical and proteomics techniques to more rapidly discover protein drugs that can treat metabolic diseases, according to the IU news release.

